The enigma of cell death in neurodegenerative disorders

Journal of Neural Transmission, Supplement

Volumn 60, Issue , 2000, Pages 21-36

  Jellinger, K A ^a   Stadelmann, Ch ^b,c  

^a Institute of Clinical Neurobiology   (Australia)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; CASPASE 3; DNA FRAGMENT;

ALZHEIMER DISEASE; CELL DEATH; CONFERENCE PAPER; DEGENERATIVE DISEASE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; PARKINSON DISEASE; PRIORITY JOURNAL;

APOPTOSIS; BRAIN; DNA FRAGMENTATION; HUMANS; IN SITU NICK-END LABELING; INCLUSION BODIES; NEURODEGENERATIVE DISEASES; NEUROGLIA; NEURONS;

EID: 0034520112     PISSN: 03036995     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-7091-6301-6_2     Document Type: Article

References (112)

1. DNA strand breaks in Alzheimer's disease
2. DNA damage and apoptosis in Alzheimer's disease: Colocalization with c-Jun immunoreactivity, relationship to brain area and effect of post mortem delay
3. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease
4. Phosphorylation of tau, Aβ-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A
5. Association of an extended haplotype in the tau gene with progressive supranuclear palsy
6. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease
7. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease
8. Apoptosis in neuronal development and transplantation: Role of caspases and trophic factors
9. Neuropathological stageing of Alzheimer-related changes
10. Programmed cell death: Does it play a role in Parkinson's disease?
11. Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington's-disease striatum
12. Accumulation of insoluble alpha-synuclein in Dementia with Lewy Bodies
13. Multiple system atrophy - Clues from inclusions
14. Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease
15. Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease
16. Mechanisms of neuronal cell death in Alzheimer's disease
17. Apoptosis in Alzheimer disease
18. Non-apoptotic mechanisms of cell death in neurode generation (Abstr)
19. Correlates of p 53- and Fas (CD 95)-mediated apoptosis in Alzheimer's disease
20. p53- and CD95-associated apoptosis in neurodegenerative diseases
21. Multiple system atrophy: A sporadic synucleinopathy
22. Apoptosis and DNA degeneration induced by 1-methyl-4-phenylpyridinium in neurons
23. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes
24. Participation of prostate apoptosis response-4 in degeneration of dopaminergic neurons in models of Parkinson's disease
25. Apoptosis in 1-methyl-4-phenyl-1,2,3,6-tetrahydrpyridiende-treated mice (Abstr)
26. A new molecular link between the fibrillar and granulovacuolar lesions of Alzheimer's disease
27. Differential distribution of presenilin-1, Bax, and Bcl-X in Alzheimer's disease and frontotemporal dementia
28. DNA fragmentation in neurons and glial cells indicates cellular injury but not apoptosis in Pick's disease
29. Differentiation between cellular apoptosis and necrosis by combined use of in situ tailing and nick translation techniques
30. Mitochondria and apoptosis in Lewy body disorders (Abstr)
31. Nigral neurons are likely to die of a mechanism other than classical apoptosis in Parkinson's disease
32. A new molecular link between the fibrillar and granulovacuolar lesions of Alzheimer's disease
33. Increased vunerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid β-peptide toxicity: Central roles of superoxide production and caspase activation
34. Caspase-3. A vulnerability factor and final effector in apoptotitc death of dopaminergic neurons in Parkinson's disease
35. Motor neuronal death in sporadic amyotrophic lateral sclerosis (ALS) is not apoptotic. A comparative study of ALS and chronic aluminium chloride neurotoxicity in New Zealand white rabbits
36. Neuronal apoptosis induced by β-amyloid is mediated by caspase-8
37. What is new in degenerative dementia disorders?
38. Mechanisms of cell death in Parkinson's disease and related disorders
39. Cell death mechanisms in Parkinson's disease
40. Mechanisms of cell death in neurodegenerative disorders
41. Activation of caspase-3 in developmental models of programmed cell death in neurons of the substantia nigra
42. Inhibition of NF-CB potentiates amyloid β-mediated neuronal apoptosis
43. Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production
44. Tissue pH as an indicator of mRNA preservation in post-mortem brain
45. DNA fragmentation in human substantia nigra: Apoptosis or perimortem effect?
46. Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease
47. Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease
48. On the question of apoptosis in the parkinsonian substantia nigra
49. Novel Leu723Pro amyloid precursor protein mutation increases amyloid β42(43) peptide levels and induces apoptosis
50. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure
51. The definition of multiple system atrophy: A review of recent developments
52. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ
53. β-amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells
54. A secoad cytotoxic proteolytic peptide derived from amyloid β-protein precursor
55. Presenilins and cellular damage: A link through amyloid?
56. DNA damage distribution in the human brain as shown by in situ end labelling. Area-specific differences in aging and Alzheimer's disease in the absence of apoptotic morphology
57. Expression of Fos, Jun, and Krox family proteins in Alzheimer's disease
58. Apoptosis, oncosis, and necrosis. An overview of cell death
59. Evidence for apoptosis in Alzheimer's disease
60. Quantitative neuronal c-Fos and c-Jun expression in Alzheimer's disease
61. Upregulation of the anti-apoptotic protein Bcl-2 may be early event in neurodegeneration: Studies on Parkinson's incidental Lewy body disease
62. Neuronal death in amyotrophic lateral sclerosis is apoptosis: Possible contribution of a programmed cell death mechanism
63. Caspase dependent DNA fragmentation might be associated with excitotoxicity in Alzheimer disease
64. Myelin degeneration in multiple system atrophy detected by unique antibodies
65. Amyloid β-peptide induces apoptosis-related events in synapses and dendrites
66. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB International Workshop
67. Abnormal expression of the cell cycle regulators P 16 and CDK 4 in Alzheimer's disease
68. Neuropharmacologic aspects of apoptosis: Significance for neurodegenerative diseases
69. c-Jun, JNK/SAPK kinases and transcription factor NF-kappa B are selectively activated in astrocytes, but not in motor neurons in amyotrophic lateral sclerosis
70. Caspase cleavage of APP results in a cytotoxic proteolytic peptid
71. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathological assessment of Alzheimer's disease
72. Apoptosis in neurodegenerative disorders
73. Caspase activities and tumor necrosis factor receptor R1 (p 55) level are elevated in the substantia nigra from Parkinsonian brains
74. Neurons may live for decades with neurofibrillary tangles
75. Expression of cell division markers in the hippocampus of Alzheimer's disease and other neurodegenerative conditions
76. Fas antigen expression in brains of patients with Alzheimer-type dementia
77. Selective increase in cellular A beta 42 is related to apoptosis but not necrosis
78. Etiology and pathogenesis of Parkinson's disease
79. Neurodegeneration in Parkinson's disease
80. DNA-fragmentation, gliosis and histological hallmarks of Alzheimer's disease
81. A suicide note from Alzheimer disease neurons?
82. Apoptosis and Alzheimer's disease
83. Neuronal cell death
84. Evidence for apoptotic cell death in Huntington's disease and excitotoxic animal models
85. Cell mechanisms in multiplesystem atrophy
86. In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease
87. Progressive neuronal DNA damage associated with neurofibrillary tangle formation in Alzheimer's disease
88. Ultrastructural analysis and TUNEL demonstrate motor neuron apoptosis in Werdnig-Hoffmann Disease
89. Evidence for apoptotic cell death in Alzheimer's disease
90. Apoptosis in Alzheimer disease; fact or fiction
91. IN situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system
92. Alzheimer Disease: DNA fragmentation indicates increased neuronal vulnerability but not apoptosis
93. Activation of caspase-3 in single apopototic neurons and granules of granulovacuolar degeneration in Alzheimer disease and Down's syndrome: A role for autophagy as antiapoptotic counterregulatory mechanism?
94. Bax protein expression is increased in Alzheimers brain: Correlations with DNA damage, Bcl-2 expression, and brain pathology
95. DNA damage and activated caspase-3 expression in neurons and astrocytes: Evidence for apoptosis in frontotemporal dementia
96. Apoptosis in neurodegenerative diseases: The role of mitochondria
97. Mitochondrial permeability in neuronal death: Possible relevance to the pathogenesis of Parkinson's disease
98. Contribution of somal Lewy bodies to neuronal death
99. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons
100. GADD 45 is induced in Alzheimer's disease, and protects against apoptosis in vtro
101. Bcl-2 and Bax protein expression in neurofibrillary tangles in progressive supranuclear palsy
102. Bcl-2 and Bax protein expression in Alzheimer's disease
103. Fatal attractions - Abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body-dementia
104. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein
105. The cause of neuronal degeneration in Alzheimer's disease
106. Generation of antiapoptotic presenilin-2 polypeptides by alternative transcription, proteolysis, and caspase-3 cleavage
107. Expression of Bcl-2 in adult human brain regions with special reference to neurodegenerative disorders
108. Calpain and caspase; can you tell the difference?
109. Cell death and apoptosis regulating proteins in Parkinson's disease - A cautionary note
110. Cell death: The significance of apoptosis
111. G-protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of APP
112. Apopototic activities of wild-type and Alzheime's disease related mutant presenilins in Drosophila melanogaster